title: The cisplatin-methotrexate neo-adjuvant protocol as first-line therapy of bladder cancer. Present experience in Palermo.
authors: Institute of Urology, University of Palermo, Italy.
authors: G B
authors: GB
authors: Ingargiola
authors: M
authors: M
authors: Lamartina
authors: G
authors: G
authors: Cassata
authors: G
authors: G
authors: Corselli
authors: V
authors: V
authors: Serretta
authors: G
authors: G
authors: Caramia
authors: F P
authors: FP
authors: Rizzo
authors: M
authors: M
authors: Pavone-Maculuso
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000601:surgery; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D011300:Preoperative Care; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
chemical_list: D002945:Cisplatin; D008727:Methotrexate